Poolbeg Pharma (POLB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 3.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 9.10p
  • 52 Week Low: 2.40p
  • Currency: UK Pounds
  • Shares Issued: 697.20m
  • Volume: 573,840
  • Market Cap: £24.40m

Regulatory News

Interim Results for the six months to 30 June 2025 29-Sep-2025 07:00 RNS
POLB 001 Phase 2a Trial Update 25-Sep-2025 07:00 RNS
Notification of Major Holdings 01-Jul-2025 16:24 RNS
Notification of Major Holdings 26-Jun-2025 07:00 RNS
Director/PDMR Shareholding 25-Jun-2025 08:00 RNS
Results of GM and AGM Meetings 23-Jun-2025 14:57 RNS
FDA Orphan Drug Designation granted for POLB 001 27-May-2025 07:01 RNS
Annual Report, AGM Notice & Circular 27-May-2025 07:00 RNS
Result of upsized oversubscribed BookBuild Offer 23-May-2025 07:00 RNS
Increase of BookBuild Offer 22-May-2025 13:44 RNS
Result of Placing and Notice of General Meeting 20-May-2025 12:26 RNS
Proposed Retail Offer to raise up to £100,000 20-May-2025 07:02 RNS
Proposed Fundraising to raise approximately ... 20-May-2025 07:01 RNS
Results for the year ended 31 December 2024 20-May-2025 07:00 RNS
Form 8.5 (EPT/NON-RI) 25-Feb-2025 08:50 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Poolbeg Pharma Market Data

Currency UK Pounds
Share Price 3.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 9.10p
52 Week Low 2.40p
Volume 573,840
Shares Issued 697.20m
Market Cap £24.40m

Poolbeg Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
53.79% below the market average53.79% below the market average53.79% below the market average53.79% below the market average53.79% below the market average
7.32% below the sector average7.32% below the sector average7.32% below the sector average7.32% below the sector average7.32% below the sector average
Price Trend
87.96% below the market average87.96% below the market average87.96% below the market average87.96% below the market average87.96% below the market average
77.27% below the sector average77.27% below the sector average77.27% below the sector average77.27% below the sector average77.27% below the sector average
Income Not Available
Growth Not Available

Poolbeg Pharma Dividends

No dividends found

Trades for 24-Oct-2025

Time Volume / Share Price
16:36 15,000 @ 3.46p
16:13 50,000 @ 3.48p
15:25 54 @ 3.65p
15:08 139,554 @ 3.58p
11:02 84,872 @ 3.53p

Poolbeg Pharma Key Personnel

CEO Jeremy Skillington
CFO Ian O’Connel

Top of Page